Inactive Instrument

Motif Bio plc Stock

Equities

Duration

Period

Style

MOTF BIO : BiVictriX Debuts on London's AIM Segment After $10 Million IPO	21-08-11	MT
Motif Bio plc Announces Board Appointments	21-06-14	CI
BiVictriX Therapeutics Ltd. cancelled the acquisition of Motif Bio plc in a reverse merger transaction.	21-06-13	CI
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-10	CI
Motif Bio plc Announces Board Changes	21-05-10	CI
Orange Avenue Technologies LLC entered into a Stock Purchase Agreement to acquire Motif BioSciences, Inc. from Motif Bio plc	21-02-25	CI
Motif Bio : Signs Reverse Takeover of Antibody-Drug Conjugate Company	21-01-27	MT
BiVictriX Therapeutics Ltd. entered into a sale and purchase agreement to acquire Motif Bio plc for £5.5 million in a reverse merger transaction.	21-01-26	CI
Motif Bio plc Reports Earnings Results for the Half Year Ended June 30, 2020	20-10-12	CI
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2019	20-09-01	CI
Motif Bio plc Announces Delay in Publication of Final Results for the Year Ended 31 December 2019	20-06-22	CI
Motif Bio Appoints Adviser for Reverse Takeover Candidate	20-06-01	CI
Motif Seeks Reverse Takeover Candidate	20-05-05	CI
Motif Bio plc Announces Management Changes	20-05-04	CI
Motif Bio plc and Motif BioSciences Inc. Enter into Loan Amendment and Release Agreement with Hercules Capital In	20-01-29	CI

Motif Bio : 2020 Annual Report and Accounts	21-05-10	PU
Motif Bio : Results of AGM	20-09-30	PU
Motif Bio : Notification of Interim Results	20-09-23	PU
Motif Bio : Annual Report and Accounts & Notice of AGM	20-09-09	PU
Motif Bio : Delay in publication of Final Results	20-06-22	PU

19-02-14

Motif Bio plc is a United Kingdom-based shell company. The Company is not engaged in any operation.

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.34%	102B
REGENERON PHARMACEUTICALS, INC.	+2.31%	97.22B
ARGENX SE	+4.22%	22.27B
BIONTECH SE	-16.72%	20.84B
GENMAB A/S	-4.50%	19.19B
WUXI APPTEC CO., LTD.	-41.75%	16.76B
BEIGENE, LTD.	-23.26%	14.76B
NEUROCRINE BIOSCIENCES, INC.	-0.02%	13.54B
SAREPTA THERAPEUTICS, INC.	+22.69%	11.53B